Altimmune Inc (NASDAQ:ALT) shares traded -1.65% lower at $9.86 on Wall Street last session.
ALT stock price is now -4.91% away from the 50-day moving average and 85.33% away from the 200-day moving average. The market capitalization of the company currently stands at $529.78M.
With the price target of $13, Goldman recently initiated with Neutral rating for Altimmune Inc (NASDAQ: ALT). On March 22, 2023, Goldman Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $20 to quote $6, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Drutz David, Director bought 300 shares of the company’s stock on Aug 15 ’23. The stock was bought for $862 at an average price of $2.88. Upon completion of the transaction, the Director now directly owns 29,785 shares in the company, valued at $0.29 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 24 ’23, Chief Financial Officer Eisenstadt Richard I bought 10,000 shares of the business’s stock. A total of $43,140 was incurred on buying the stock at an average price of $4.31. This leaves the insider owning 22,010 shares of the company worth $0.22 million. A total of 1.02% of the company’s stock is owned by insiders.
During the past 12 months, Altimmune Inc has had a low of $2.09 and a high of $14.84. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 12.89, and a quick ratio of 12.89. The fifty day moving average price for ALT is $10.37 and a two-hundred day moving average price translates $5.35 for the stock.
The latest earnings results from Altimmune Inc (NASDAQ: ALT) was released for Sep, 2023. According to the Biotechnology Company, earnings per share came in at -$0.39, beating analysts’ expectations of -$0.42 by 0.03. This compares to -$0.48 EPS in the same period last year. The net profit margin was -28124.01% and return on equity was -44.15% for ALT. The company reported revenue of $0.36 million for the quarter, compared to $2000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 18000.0 percent.
